Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 2087

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 2
Chunk 2087
---
ley Act of 2002.

    32.1*#
     
    Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C.
    Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2022.

    97.1
     
    CERo Therapeutics Holdings Inc. Compensation Recovery Policy (incorporated by reference to Exhibit 97.1 to the Annual Report on Form 10-K filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on April 2, 2024).

    101.INS
     
    Inline XBRL Instance Document (embedded within the Inline XBRL document).

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document.

    101.CAL
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.

    101.DEF
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document.

    101.LAB
     
    Inline XBRL Taxonomy Extension Label Linkbase Document.

    101.PRE
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document.

    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document).

*Filed herewith.

+Indicates management contract or compensatory plan.

#The certifications furnished in Exhibit 32.1 hereto are deemed to accompany this report and will not be deemed “filed”
for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings
under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

Item 16. Form 10-K Summary.

None.

117

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Annual Report on Form 10-K to be signed on its
behalf by the undersigned, thereunto duly authorized.

    CERO THERAPEUTICS HOLDINGS, INC.

    Date:  April 15, 2025
    By:
    /s/ Chris Ehrlich

    Chris Ehrlich

    Chairman, Chief Executive Officer and Director

    (Principal Executive Officer)

    Date:  April 15, 2025
    By:
    /s